Dare Bioscience Investor Presentation Deck
Females age 15-44 (MM)
69
68
64
63
62
63.6
63.9
64.2
Women in the Reproductive Health &
Contraception Market Segment
(over 60 million women)
64.6
45.0
45.4
Total US Females Age 15-44 (Millions)
65.8
462
46.5
2016 2017 2018 2019 2020 2021 2022 2023 2024
Contraception: Large Market Opportunity
66.7
46.8
47.0
67.2
67.3
67.5
67.6
47.8
48.0
3.https://www.sec.gov/Archives/edgar/data/0000310158/000031015819000014/mrk1231201810k.htm
68.1
48.1
2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035
Year
Source: US Census Bureau, 2017 National Dataset (2016 is base population estimate for projection)
https://www.census.gov/programs surveys/popproj.html
1.https://www.bayer.com/en/bayer-ag-annual-report-2019.pdfx. Includes sales for Mirena, Kyleena and JaydessⓇ/Skyla
2.https://www.prnewswire.com/news-releases/allergan-reports-fourth-quarter-and-full-year-2019-financial-results-301001646.html
Successful Contraceptive Brands Peak Sales:
Mirena® Hormone IUD
(levonorgestrel-releasing intrauterine
system) 52mg
Physician inserted, long-acting.
low/locally delivered hormone
IUS
2020 worldwide sales: €1.2
billion (Bayer)¹
How to use Nuvaking
Lo Loestrin
(norethindrone acetate and ethinyl
estradiol, ethinyl estradiol tablets)
Lowest amount of daily estrogen
(10 micrograms) available in pill form
2019 US sales: $588 million
(Allergan)²
NuvaRingⓇ
(etonogestrel/ethinyl estradiol
vaginal ring)
Lo Loestrin Fe
dette and inte
tiratiotit at onc lorum tilet
1101
Monthly vaginal ring
2018 worldwide sales: $900 million
(Merck)³
23View entire presentation